<DOC>
	<DOCNO>NCT02427217</DOCNO>
	<brief_summary>This multicenter , non interventional , retrospective cohort study prospective , observational follow-up component investigate safety efficacy FCH use subject congenital fibrinogen deficiency . Data collect safety efficacy FCH use treatment acute bleed episode , routine prophylaxis perioperative bleeding subject . All subject receive FCH may continue receive FCH discretion treat physician / Primary Investigator accord standard care participate study site .</brief_summary>
	<brief_title>An Observational Cohort Study Safety Efficacy Fibrinogen Concentrate , Human ( FCH ) Subjects With Congenital Fibrinogen Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Afibrinogenemia</mesh_term>
	<criteria>Male female subject age diagnosis congenital fibrinogen deficiency . Have receive FCH ( Haemocomplettan® P RiaSTAP® ) treatment bleeding , surgery prophylaxis .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>